2025年第20届EASD糖尿病足研究组科学会议(DFSG)

2025年第20届EASD糖尿病足研究组科学会议(DFSG)

◆ 会议时间:2025年9月12-14日
◆ 会议地点:捷克 布拉格

 

◆ 会议简介:

2025年欧洲糖尿病研究协会(EASD)糖尿病足研究小组(DFSG)第20次科学会议将于2025年9月12-14日在捷克布拉格举行。DFSG会议是糖尿病足领域的一个独特事件,是糖尿病专家、足病医生、专科护士、矫形外科医生和血管外科医生,以及对糖尿病患者足部问题感兴趣的所有其他专家之间宣真正的跨学科合作。DFSG会议的影响远远超出了DFSG的参与者,会议已影响到了所有对糖尿病领域感兴趣的人们。通过DFSG会议可以:可以了解欧洲糖尿病足研究的最新进展;了解足部溃疡和夏科足的风险因素;怎样通过技术预防足部溃疡并促进伤口愈合;糖尿病足伤口治疗的实践与创新。

欧洲糖尿病研究协会(EASD)糖尿病足研究小组(DFSG)致力于提高有关糖尿病足部护理各方面知识的进步,这是通过内分泌学家、糖尿病专家、足病医生、专科护士、矫形外科医生和血管外科医生和其他关心糖尿病患者脚部问题专家们之间的积极合作与协作完成。——未经许可禁止复制转载镜像本站任何内容—国际医学会议网(lingyuint.com)。

DFSG 2025 -20th Meeting of the Diabetic Foot Study Group (DFSG)

Date: 12 – 14 September 2025
Venue: Prague, Czech Republic


摘要征文投稿:

Important dates:

SUBMISSION DEADLINE: 1 APril 2025, 23.59 CEST
Abstract notification: mid may 2025
Abstract submission opens: february 2025

点此提交摘要>>>Submit Abstract>>>

 

The abstract word limit is max. 300 words excl. title, authors and affiliations.

Pictures and tables: Can be included if you paste them into your word file.

Language: All abstracts must be submitted and presented in English.

Submission categories:

  • Epidemiology
  • Basic and clinical science
  • Diagnostics
  • DNOAP
  • Classification
  • Foot clinics
  • Biomechanics
  • Orthopaedic surgery
  • Infection
  • Revascularisation
  • Uraemia
  • Wound healing and outcome
  • Other

General instructions:

The title should be as brief as possible but long enough to clearly indicate the nature of the study.
Names of authors may not be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract

Accepted abstracts will be published on the conference website

By submitting an abstract you consent to giving DFSG permission to publish your abstracts in connection to the conference.

Withsdrawal of abstracts can be done in writing to the DFSG Secretariat.

The presenting author must register for the conference.

 


 

 

,

© 版权声明

相关文章

暂无评论

none
暂无评论...